Patrick R. Trucchio
Stock Analyst at HC Wainwright & Co.
(3.70)
# 754
Out of 5,245 analysts
83
Total ratings
45.88%
Success rate
9.37%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Patrick R. Trucchio
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GHRS GH Research | Maintains: Buy | $70 → $65 | $23.00 | +182.61% | 3 | May 19, 2026 | |
| ALT Altimmune | Maintains: Buy | $25 → $20 | $2.93 | +582.59% | 4 | May 18, 2026 | |
| ANRO Alto Neuroscience | Reiterates: Buy | $50 | $21.55 | +132.02% | 4 | May 11, 2026 | |
| QURE uniQure | Maintains: Buy | $70 → $50 | $24.84 | +101.29% | 8 | May 6, 2026 | |
| ALNY Alnylam Pharmaceuticals | Reiterates: Buy | $510 | $299.00 | +70.57% | 6 | May 5, 2026 | |
| ASMB Assembly Biosciences | Reiterates: Buy | $50 | $31.25 | +60.00% | 4 | May 4, 2026 | |
| CMPS COMPASS Pathways | Reiterates: Buy | $70 | $11.82 | +492.22% | 2 | Apr 28, 2026 | |
| NRXP NRx Pharmaceuticals | Reiterates: Buy | $45 | $3.19 | +1,311.10% | 6 | Apr 27, 2026 | |
| IMCR Immunocore Holdings | Reiterates: Buy | $100 | $29.26 | +241.76% | 4 | Apr 20, 2026 | |
| ARWR Arrowhead Pharmaceuticals | Reiterates: Buy | $100 | $75.82 | +31.89% | 6 | Mar 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $4.45 | +461.80% | 3 | Mar 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $3.80 | +557.89% | 3 | Mar 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 | $6.55 | +1,045.04% | 2 | Mar 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $50 | $6.00 | +733.33% | 3 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $5 | $0.1978 | +2,427.81% | 2 | Mar 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $115 → $145 | $82.55 | +75.65% | 4 | Mar 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $20 | $9.07 | +120.51% | 3 | Mar 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $30.79 | +94.87% | 4 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $55 → $95 | $4.72 | +1,912.71% | 1 | Mar 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $55 → $70 | $22.58 | +210.01% | 1 | Mar 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $55 | $30.36 | +81.16% | 3 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $1.45 | +589.66% | 1 | Dec 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $10 | $0.80 | +1,150.00% | 1 | Nov 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $10 | $1.12 | +796.86% | 3 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $28.42 | +181.49% | 2 | Oct 10, 2025 |
GH Research
May 19, 2026
Maintains: Buy
Price Target: $70 → $65
Current: $23.00
Upside: +182.61%
Altimmune
May 18, 2026
Maintains: Buy
Price Target: $25 → $20
Current: $2.93
Upside: +582.59%
Alto Neuroscience
May 11, 2026
Reiterates: Buy
Price Target: $50
Current: $21.55
Upside: +132.02%
uniQure
May 6, 2026
Maintains: Buy
Price Target: $70 → $50
Current: $24.84
Upside: +101.29%
Alnylam Pharmaceuticals
May 5, 2026
Reiterates: Buy
Price Target: $510
Current: $299.00
Upside: +70.57%
Assembly Biosciences
May 4, 2026
Reiterates: Buy
Price Target: $50
Current: $31.25
Upside: +60.00%
COMPASS Pathways
Apr 28, 2026
Reiterates: Buy
Price Target: $70
Current: $11.82
Upside: +492.22%
NRx Pharmaceuticals
Apr 27, 2026
Reiterates: Buy
Price Target: $45
Current: $3.19
Upside: +1,311.10%
Immunocore Holdings
Apr 20, 2026
Reiterates: Buy
Price Target: $100
Current: $29.26
Upside: +241.76%
Arrowhead Pharmaceuticals
Mar 25, 2026
Reiterates: Buy
Price Target: $100
Current: $75.82
Upside: +31.89%
Mar 17, 2026
Reiterates: Buy
Price Target: $25
Current: $4.45
Upside: +461.80%
Mar 17, 2026
Reiterates: Buy
Price Target: $25
Current: $3.80
Upside: +557.89%
Mar 13, 2026
Reiterates: Buy
Price Target: $75
Current: $6.55
Upside: +1,045.04%
Mar 11, 2026
Reiterates: Buy
Price Target: $50
Current: $6.00
Upside: +733.33%
Mar 6, 2026
Maintains: Buy
Price Target: $10 → $5
Current: $0.1978
Upside: +2,427.81%
Mar 4, 2026
Maintains: Buy
Price Target: $115 → $145
Current: $82.55
Upside: +75.65%
Mar 4, 2026
Maintains: Buy
Price Target: $15 → $20
Current: $9.07
Upside: +120.51%
Mar 3, 2026
Reiterates: Buy
Price Target: $60
Current: $30.79
Upside: +94.87%
Mar 2, 2026
Maintains: Buy
Price Target: $55 → $95
Current: $4.72
Upside: +1,912.71%
Mar 2, 2026
Maintains: Buy
Price Target: $55 → $70
Current: $22.58
Upside: +210.01%
Feb 25, 2026
Reiterates: Buy
Price Target: $55
Current: $30.36
Upside: +81.16%
Dec 8, 2025
Initiates: Buy
Price Target: $10
Current: $1.45
Upside: +589.66%
Nov 17, 2025
Maintains: Buy
Price Target: $5 → $10
Current: $0.80
Upside: +1,150.00%
Nov 3, 2025
Maintains: Buy
Price Target: $5 → $10
Current: $1.12
Upside: +796.86%
Oct 10, 2025
Reiterates: Buy
Price Target: $80
Current: $28.42
Upside: +181.49%